In the course of screening for microbial products with antitumor activity, new antitumor agents, clecarmycins, were isolated from culture broth of Streptomyces sp. DO-114. The antibiotics were produced in a fermentation mediumsupplemented with a highly porous polymer resin which adsorbs antibiotics and results in a increase of titer. Active materials were separated from the polymer resin by solvent extraction procedure and two components named clecarmycin Al and C were isolated by silica gel column chromatography. These were active against bacteria, and showed antiproliferative activities against humanHeLa S3 cells. Clecarmycins exhibited antitumor activity against leukemia P388 and sarcoma 180 in mice.
Most clinically
useful antitumor agents including mitomycin C, adriamycin, bleomycin and cis-platin function by initiating DNA damaged With this knowledge, we focused our efforts on the discovery of novel DNA-active antitumor antibiotics, and have screened cultures of actinomycetes and fungi using a microbial prescreen (DC screening) with both wild type of Bacillus subtilis and strains which are supersensitive to DNA-active drugs2). In the course of our continued DCscreening program, a culture designated DO-114 was isolated from a soil of Japan and was found to produce antitumor compounds ( Fig. 1) . Two active components named clecarmycin Al and C were isolated. The clecarmycins inhibited the growth of rec~and polA" strains of Bacillus subtilis more selectively than that of wild type, suggesting that DNA is the primary target of the clecarmycins. Clecarmycins showed antimicrobial and anticellular activity in vitro, and antitumor activity in vivo. Wereport here the taxonomy of the producing strain, fermentation, isolation and biological activity of clecarmycins. Physico-chemical properties and structure determination of these compoundsare reported in the following paper3).
Materials and Methods

Microorganism
The producing microorganismwas isolated from a soil sample collected at Ami-cho, Ibaragi, Japan. 
Anticellular and Antitumor Activity
Humanuterine cervix carcinoma HeLa S3 cells were obtained from American Type Culture Collection through Dainippon Pharmaceutical Co. (Osaka, Japan). Cytotoxicity was determined as described previously7).
Antitumor activity in vivo was determined as follows8'9*. P388 cells (1 x 106 cells/mouse) were transplanted ip into CD2F! mice on day 0, and drugs were administered ip on day 1. Antitumor efficacy was expressed as a percentage of increase in life span (ILS). Sarcoma 180 (5 x 106cells/mouse) was inoculated sc at the axillary region in ddY mice on day 0. Drugs were administrated ip or iv on day 1 and the tumor volume was measured on day 7. These experiments were conducted with 5 mice in a group.
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Results and Discussion
Taxonomyof the Producing Strain
The appearance of strain DO-1 14 on nine solid media is presented in Table 1 . The vegetative mycelia grew on both synthetic and complexmedia. The aerial mycelium was gray to white colored and branched. It bore chains of 10 to 30 or more spores which were in the form of curves or loops. Scanning electron micrographs indicated that the spore was oval, in size 0.5x0.7^m, and smooth-surfaced (Fig. 2) . The substrate mycelium was branched but not fragmented. at 28°C, 6ml of the resulting seed culture was inoculated into a 2-liter Erlenmyer flask containing 300 ml of the same seed medium and culture as described above. After 24 hours, 1.8 liters of the second culture was inoculated into a 200-liter fermenter containing 100 liters of the same seed mediumand cultured at 28°C for 22 hours under aeration at 60 liters per minute with agitation at 150rpm. 100 liters of the third seed culture was transferred into a 2000-liter tank fermenter containing 1 000 liters of fermentation medium and cultured at 27°C under aeration at 400 liters per Abbreviations: G, growth degree; AM, formation and color tone of aerial mycelium; SM, color tone of substrate mycelium; P, color tone of soluble pigment. minute with agitation at 120 rpm. High porous polymer resin Diaion HP-20 (50 liters) was added at 18 hours of incubation, because examination in shake flasks indicated that the addition of Diaion HP-20 resin (5 volume %) to the fermentation mediumresulted in a significant increase in accumulation of clecarmycins (data not shown). Fig. 3 shows a typical time course for production of clecarmycins in a 2000-liter tank fermentation, The clecarmycin C production increased concomitantly with gradual increase of mycelium volume and reached a maximum at 46 hours.
Isolation
The clecarmycins were isolated from the culture broth described above by the following procedure. The whole culture broth was passed through a vibrating screen (Kawasaki heavy industries, LTD. Japan) in order to isolate resin from mycelia. The recovered Diaion HP-20 resin was suspended in deionized water and then packed into a column. The column was washed with 150 liters of deionized water-MeOH (1 : 1) and eluted with 150 liters ofMeOH. The active eluate was concentrated under reduced pressure to give an aqueous solution (5 liters). The aqueous solution was diluted with an equal volume of water and extracted twice with 10 liters of EtOAc.
The active EtOAc extract was concentrated after dehydration over anhydrous Na2SO4 to give a crude powder. The clecarmycins crude powder was applied to a silica gel column chromatography (10 liters, BW-300, Fuji Davison, Japan). The column was washed with precipitates. The resulting precipitates were collected and dried in vacuo to afford clecarmycin Al (0.67g) and clecarmycin C (3.6g).
Biological Activity Antimicrobial Activity The antimicrobial activity of the clecarmycins is shown in Table 3 . The clecarmycins exhibited antimicrobial activity, particularly against Gram-positive bacteria. Clecarmycin Al was more active than clecarmycin C against Gram-negative bacteria and C. albicans with MIC values in the /ig/ml range. Anticellular Activity Clecarmycins were potent cytotoxic agents in the ng/ml range against HeLa S3 cells in vitro ( Table 4 ). The IC50 value of clecarmycin Al and C against HeLa S3 cells were 6.58 ng/ml and 1 1.6ng/ml respectively which were 10~20-fold more active than adriamycin.
Antitumor Activity on Ascitic Tumor (P388) in Mice
The antitumor activity of the clecarmycins against T : survival days of treated mice, C : survival days of control mice b Survivors more than 30 days. P388 leukemia were examined and compared with that of adriamycin by single ip administration ( Table 5 ). As shown in Table 5 , clecarmycin Al and C prolonged the life span of mice bearing P388 leukemia with the maximumILS of 53% and 75% respectively which were less active than that (> 177%) observed for adriamycin.
Antitumor Activity on Murine Solid Tumor (Sarcoma
180) in Mice
The antitumor activity of the clecarmycins against Sarcoma 180 were examined by single ip or iv administration (Table 6 ). When the drugs were given by ip administration, clecarmycin Al and C showed antitumor activity against sarcoma 180 with T/C values less than 40%. While by iv administration, clecarmycin C showed the strongest activity with the minimumT/C of 20%, which was superior to that (T/C 31%) of adriamycin, whereas clecarmycin Al showed the marginal regression (T/C 58%) in this system. Further studies on the antitumor activities of clecarmycins are in progress.
